

What's This?
In its Nov. 13, 2008, issue, the New England Journal of Medicine starts a dialogue on a cure for what ails primary care. Featured is a panel discussion moderated by Dr. Thomas Lee, an associate editor of the journal, with 4 experts in primary care and related policy: Drs. Thomas Bodenheimer, Allan Goroll, Barbara Starfield, and Katharine Treadway. In addition, the panelists and Dr. Martin Roland from the United Kingdom provide essays exploring the current crisis in U.S. primary care and...
In its Nov. 13, 2008, issue, the New England Journal of Medicine starts a dialogue on a cure for what ails primary care. Featured is a panel discussion moderated by Dr. Thomas Lee, an associate editor of the journal, with 4 experts in primary care and related policy: Drs. Thomas Bodenheimer, Allan Goroll, Barbara Starfield, and Katharine Treadway. In addition, the panelists and Dr. Martin Roland from the United Kingdom provide essays exploring the current crisis in U.S. primary care and possible solutions for training, practice, compensation, and systemic change.
Read the full report at NEJM online.
What's This?
The prevalence of reported food or digestive allergy among children aged younger than 18 years increased 18% from 1997 to 2007, according to a briefing from the National Center for Health Statistics.
What's This?
Patients with type 2 diabetes who take metformin hydrochloride may receive moderate protection against adverse cardiovascular outcomes, while rosiglitazone maleate may increase the risk of such events, suggests a new meta-analysis. But researchers caution that large, long-term studies are required to draw firm conclusions about the major clinical benefits and risks related to oral diabetes agents.
What's This?
WATCH VIDEO from AHA
What's This?
Results from 2 new studies do not support the use of aspirin for the primary prevention of cardiovascular events in people with diabetes.